leflunomid mylan 20 mg filmtabletten
mylan dura gmbh (8006829) - leflunomid - filmtablette - teil 1 - filmtablette; leflunomid (24525) 20 milligramm
leflunomid mylan 10 mg filmtabletten
mylan dura gmbh (8006829) - leflunomid - filmtablette - teil 1 - filmtablette; leflunomid (24525) 10 milligramm
methotrexat stada 25 mg/ml injektionslösung in einer fertigspritze
stadapharm, gesellschaft mit beschränkter haftung (3364435) - methotrexat - injektionslösung in einer fertigspritze - teil 1 - injektionslösung in einer fertigspritze; methotrexat (00658) 25 milligramm
mtx hexal 25 mg/ml injektionslösung, fertigspritze
h e x a l aktiengesellschaft (3079284) - methotrexat - injektionslösung in einer fertigspritze - methotrexat (00658) 25 milligramm
pirfenidon stada 267 mg filmtabletten
stadapharm gmbh (3364435) - filmtablette - 267 mg
pirfenidon stada 534 mg filmtabletten
stadapharm gmbh (3364435) - filmtablette - 534 mg
pirfenidon stada 801 mg filmtabletten
stadapharm gmbh (3364435) - filmtablette - 801 mg
cimzia
ucb pharma sa - certolizumab pegol - morbus crohn - immunsuppressiva - cimzia, in combination with methotrexate (mtx), is indicated for the treatment of moderate to severe, active rheumatoid arthritis (ra) in adult patients when the response to disease-modifying antirheumatic drugs (dmard) including methotrexate, has been inadequate. cimzia als monotherapie im falle einer unverträglichkeit gegenüber methotrexat oder wenn die fortsetzung der behandlung mit methotrexat ungeeignet ist,. cimzia has been shown to reduce the rate of progression of joint damage as measured by x-ray and to improve physical function, when given in combination with methotrexate.
eucreas
novartis europharm limited - vildagliptin, metformin-hydrochlorid - diabetes mellitus, typ 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - eucreas is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.